Your browser doesn't support javascript.
loading
Modeling anxiety in Parkinson's disease.
Broen, Martijn P G; Köhler, Sebastian; Moonen, Anja J H; Kuijf, Mark L; Dujardin, Kathy; Marsh, Laura; Richard, Irene H; Starkstein, Sergio E; Martinez-Martin, Pablo; Leentjens, Albert F G.
Afiliação
  • Broen MP; Department of Neurology, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Köhler S; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Moonen AJ; Department of Psychiatry, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Kuijf ML; Department of Neurology, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Dujardin K; Neurology and Movement Disorders Unit, Lille University Medical Center, Lille, France.
  • Marsh L; Departments of Psychiatry and Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Richard IH; Departments of Neurology and Department of Psychiatry, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.
  • Starkstein SE; School of Psychiatry, University of Western Australia and Fremantle Hospital, Fremantle, Western Australia, Australia.
  • Martinez-Martin P; Area of Applied Epidemiology, National Center for Epidemiology, and CIBERNED, Carlos III Institute of Health, Madrid, Spain.
  • Leentjens AF; Department of Psychiatry and Neuropsychology, School for Mental Health and Neuroscience, Alzheimer Center Limburg, Maastricht University Medical Center, Maastricht, The Netherlands.
Mov Disord ; 31(3): 310-6, 2016 Mar.
Article em En | MEDLINE | ID: mdl-26685935
ABSTRACT

BACKGROUND:

The aim of this work was to construct a model for anxiety in PD and compare the relative contributions of PD-specific and -nonspecific general population risk factors for anxiety in this model.

METHODS:

Structural equation modeling of associations of risk factors with the anxiety outcome using a cross-sectional data set of 342 patients with PD were used.

RESULTS:

A model with acceptable to good fit was generated that explained 65% of the variance in anxiety scores. A previous history of depression and the severity of the depressive symptoms scored on the Hamilton Depression Rating Scale were the only nonspecific variables with a direct effect on anxiety. The presence of motor fluctuations and disease-related decline in activities of daily living were PD-specific markers of anxiety. Nonspecific risk factors had a greater influence in the model than PD-specific risk factors. Standardized regression coefficients suggested that the Hamilton Depression Rating Scale score was the most important contributor to the variation in anxiety. A post-hoc analysis showed that the effects of the following variables on anxiety levels were fully mediated by depression sex; family history of depression; previous history of anxiety; cognitive status; difficulties in non-disease-specific activities of daily living; and severity of motor signs.

CONCLUSION:

In this cross-sectional study, we showed that nonspecific general population risk factors are more important markers for anxiety than PD-specific risk factors. Depression was the most prominent marker. PD-specific markers for anxiety appear to be more situational and related to off periods and disease-specific disturbances of activities of daily living.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ansiedade / Transtornos de Ansiedade / Doença de Parkinson / Atividades Cotidianas / Depressão / Transtorno Depressivo Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ansiedade / Transtornos de Ansiedade / Doença de Parkinson / Atividades Cotidianas / Depressão / Transtorno Depressivo Idioma: En Ano de publicação: 2016 Tipo de documento: Article